These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19519504)

  • 1. New insights into the pleiotropic effects of statins for stroke prevention.
    Pezzini A; Del Zotto E; Volonghi I; Giossi A; Costa P; Padovani A
    Mini Rev Med Chem; 2009 Jun; 9(7):794-804. PubMed ID: 19519504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
    Arnaud C; Veillard NR; Mach F
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and ischemic stroke.
    Liao JK
    Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
    Takemoto M; Liao JK
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
    Liao JK
    Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do HMG-CoA reductase inhibitors prevent stroke?
    Bedi A; Flaker GC
    Am J Cardiovasc Drugs; 2002; 2(1):7-14. PubMed ID: 14727994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
    Vaughan CJ
    Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in the treatment of acute ischemic stroke.
    Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F
    Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins in stroke: prevention, protection and recovery.
    Switzer JA; Hess DC
    Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond lipid lowering: the role of statins in vascular protection.
    Liao JK
    Int J Cardiol; 2002 Nov; 86(1):5-18. PubMed ID: 12243846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
    Wang CY; Liu PY; Liao JK
    Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
    Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
    Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic vascular protective effects of statins in perioperative medicine.
    Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
    Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins: immunomodulators for autoimmune rheumatic disease?
    Jury EC; Ehrenstein MR
    Lupus; 2005; 14(3):192-6. PubMed ID: 15807195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.